INEGY 10 MG20 MG TABLETS

Maa: Israel

Kieli: englanti

Lähde: Ministry of Health

Aktiivinen ainesosa:

EZETIMIBE; SIMVASTATIN

Saatavilla:

MERCK SHARP & DOHME ISRAEL LTD

ATC-koodi:

C10AA01

Lääkemuoto:

TABLETS

Koostumus:

SIMVASTATIN 20 MG; EZETIMIBE 10 MG

Antoreitti:

PER OS

Prescription tyyppi:

Required

Valmistaja:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Terapeuttinen ryhmä:

SIMVASTATIN

Terapeuttinen alue:

SIMVASTATIN

Käyttöaiheet:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Valtuutus päivämäärä:

2012-04-30